Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 34 Suppl 1, S62–S69, 2011.10.2337/dc11-S062300605121193628Open DOISearch in Google Scholar

Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 1, 1–10, 2002.10.1186/1475-2840-1-111661512119059Search in Google Scholar

Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 34, S285–290, 2011.10.2337/dc11-s239363219421525470Open DOISearch in Google Scholar

Burns TA, Geor RJ, Mudge MC, McCutcheon LJ, Hinchcliffe KW, Belknap JK. Proinflammatory cytokine and chemokine gene expression profiles in subcutaneous and visceral adipose tissue depots of insulin-resistant and insulin-sensitive light breed horses. J Vet Intern Med 24, 932–939, 2010.10.1111/j.1939-1676.2010.0551.x20649750Open DOISearch in Google Scholar

Cacho J, Sevillano J, de Castro J, Herrera E, Ramos MP. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague Dawley rats. Am J Physiol Endocrinol Metab 295, E1269–E1276, 2008.10.1152/ajpendo.90207.200818796548Search in Google Scholar

Carlquist JF, Muhlestein JB, Anderson JL. Lipoprotein-associated phospholipase A₂: a new biomarker for cardiovascular risk assessment and potential therapeutic target. Expert Mol Diagn 7, 511–517, 2007.10.1586/14737159.7.5.51117892360Open DOISearch in Google Scholar

Chait A, Bornfeldt KE. Diabetes and atherosclerosis: is there a role for hyperglycemia? J Lipid Res 50, S335–S339, 2009.10.1194/jlr.R800059-JLR200267474019029122Search in Google Scholar

Fukuchi M, Giaid A. Endothelial expression of endothelial nitric oxide synthase and endothelin-1 in human coronary artery disease: specific reference to underlying lesion. Journal of Technical Methods and Pathology 79, 659–670, 1999.Search in Google Scholar

Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27, 2292–2301, 2007.10.1161/ATVBAHA.107.14917917673705Open DOISearch in Google Scholar

Heriansyah T, Wihastuti TA, Anita KW, Iskandar A, Suhendra RB, Setiabudi PA, Sishartami LW. Atherogenesis inhibition by darapladib administration in dyslipidemia model sprague-dawley rats. National Journal of Physiology, Pharmacy and Pharmacology 6, 52–58, 2015.10.5455/njppp.2015.5.2909201580Search in Google Scholar

Heriansyah T, Adam AA, Wihastuti TA, Rohman MS. Elaborate evaluation of serum and tissue oxidized LDL level with darapladib therapy: a feasible diagnostic marker for early atherogenesis. Asian Pacific Journal of Tropical Biomedicine 7, 134–138, 2016.10.1016/j.apjtb.2016.11.014Search in Google Scholar

Hu MM, Zhang J, Wang WY, Wu WY, Ma YL, Chen WH, Wang YP. The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice. Acta Pharmacol Sin 32, 1253–1258, 2011.10.1038/aps.2011.127401008121970837Open DOISearch in Google Scholar

International Diabetes Federation: IDF Diabetes Atlas (6nd ed.), 2013.Search in Google Scholar

Navale AM, Paranjape AN. Role of inflammation in development of diabetic complications and commonly used inflammatory markers with respect to diabetic complications. Int J Pharm Pharm Sci 5, 1–5, 2013.Search in Google Scholar

Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852–871, 2012.10.1016/j.cell.2012.02.017329442022385956Search in Google Scholar

Silva IT, Mello APQ, Damasceno NRT. Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2): a review. Lipids in Health and Disease 10, 170, 2010.10.1186/1476-511X-10-170320424621955667Search in Google Scholar

Silvana GT, Rifa’i M. Activity test of Vip Albumin against blood glucose levels and lymphocytes profiles in Balb/c mice as type 2 diabetes mellitus model. Jurnal Biotropika 3, 17–20, 2015.Search in Google Scholar

Sumagin R, Lomakina E, Sarelius IH. Leukocyte-endothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling. Am J Physiol Heart Circ Physiol 295, H969–H977, 2008.10.1152/ajpheart.00400.2008254450218641276Search in Google Scholar

Thompson PL, Nidorf SM, Eikelboom J. Targeting the unstable plaque in acute coronary syndromes. Clin Ther 35, 1099–1107, 2013.10.1016/j.clinthera.2013.07.33223973042Open DOISearch in Google Scholar

Turan B, Dhalla NS. Diabetic cardiomyopathy: biochemical and molecular mechanism. Springer, New York, 2014.10.1007/978-1-4614-9317-4Search in Google Scholar

Van Dijk JW, Venema M, van Mechelen W, Stehouwer CD, Hartgens F, van Loon LJ. Effect of moderate-intensity exercise versus activities of daily living on 24-hour blood glucose homeostasis in male patients with type 2 diabetes. Diabetes Care 36, 3448–3453, 2013.10.2337/dc12-2620381688824041682Open DOISearch in Google Scholar

Wang W-y, Zhang J, Wu W-y, Li J, Ma Y-l, Chen W-h, Yan H, Wang K, Xu WW, Shen JH, Wang YP. Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice. PLoS ONE 6, e23425, 2011.10.1371/journal.pone.0023425316613021909350Search in Google Scholar

Wihastuti TA, Sargowo D, Tjokroprawiro A, Permatasari N, Widodo MA, Soeharto S. Vasa vasorum anti-angiogenesis through H2O2, HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (garcinia mangostana linn) in hypercholesterol-diet-given rattus norvegicus wistar strain. Vasc Health Risk Manag 10, 523–531, 2014.10.2147/VHRM.S61736414939025187725Search in Google Scholar

Wihastuti TA, Heriansyah H, Soraya M, Wijayanti M, Firani NK, Iskandar A, Anita KW, Agustin D, Pujiana L, Sandika N, Ardyanto E, Puji A, Wiji Y, Febriato A, Nuraminudin A, Quirino F, Rachmawati S, Candra Y. Inhibition of oxidative stress in hypercholesterolemic rats by soy milk. Journal of Cardiovascular Disease Research 7, 74–82, 2016.Search in Google Scholar

Wilensky RL, Shi Y, Mohler ER 3rd, Hamamdzic D, Burgert ME, Li J, Postle A, Fenning RS, Bollinger JG, Pelchovitz DJ, Yang J, Mirabile RC, Webb CL, Zhang L, Zhang P, Gelb MH, Walker MC, Zalewski A, Macphee CH. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 14, 1059–66, 2008.10.1038/nm.1870288513418806801Search in Google Scholar